Literature DB >> 11191931

Severe but reversible encephalopathy associated with cefepime.

P Jallon1, L Fankhauser, R Du Pasquier, A Coeytaux, F Picard, S Hefft, F Assal.   

Abstract

In this study, a report has been made of 19 cases of severe encephalopathy in patients with renal impairment who were treated during the last three years for various infections with cefepime, a new parenteral cephalosporin antibiotic. All patients (aged 57 to 91 years) presented a prolonged confusional state associated with diffuse rhythmic non-reactive triphasic sharp waves on the EEG. All the electroclinical symptomatology disappeared within 24-48 hours after discontinuation of drug administration. A clear relation was found between encephalopathy and cefepime intake. These observations underline the fact that the cefepime dosage should be reduced in renally impaired patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11191931     DOI: 10.1016/s0987-7053(00)00234-3

Source DB:  PubMed          Journal:  Neurophysiol Clin        ISSN: 0987-7053            Impact factor:   3.734


  20 in total

1.  Cefixime-induced nonconvulsive status epilepticus.

Authors:  F Anzellotti; L Ricciardi; D Monaco; F Ciccocioppo; I Borrelli; H Zhuzhuni; M Onofrj
Journal:  Neurol Sci       Date:  2011-07-01       Impact factor: 3.307

2.  High cefepime plasma concentrations and neurological toxicity in febrile neutropenic patients with mild impairment of renal function.

Authors:  F Lamoth; T Buclin; A Pascual; S Vora; S Bolay; L A Decosterd; T Calandra; O Marchetti
Journal:  Antimicrob Agents Chemother       Date:  2010-07-12       Impact factor: 5.191

3.  Ceftazidime dosage regimen in intensive care unit patients: from a population pharmacokinetic approach to clinical practice via Monte Carlo simulations.

Authors:  Bernard Georges; Jean-Marie Conil; Stéphanie Ruiz; Thierry Seguin; Pierre Cougot; Olivier Fourcade; Georges Houin; Sylvie Saivin
Journal:  Br J Clin Pharmacol       Date:  2012-04       Impact factor: 4.335

Review 4.  Ictal Interictal Continuum Patterns.

Authors:  Gamaleldin M Osman; Davi F Araújo; Carolina B Maciel
Journal:  Curr Treat Options Neurol       Date:  2018-04-18       Impact factor: 3.598

5.  Cefepime-Associated SIRPIDs in a Patient With Normal Renal Function.

Authors:  Emily Johnson; Yousef Hannawi; Nirma Carballido Martinez; Eva K Ritzl
Journal:  Neurohospitalist       Date:  2015-10-14

Review 6.  New developments in antibacterial choice for lower respiratory tract infections in elderly patients.

Authors:  Anna Maria Ferrara; Anna Maria Fietta
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

7.  Prospective monitoring of cefepime in intensive care unit adult patients.

Authors:  Thomas M Chapuis; Eric Giannoni; Paul A Majcherczyk; René Chioléro; Marie-Denise Schaller; Mette M Berger; Saskia Bolay; Laurent A Décosterd; Denis Bugnon; Philippe Moreillon
Journal:  Crit Care       Date:  2010-04-01       Impact factor: 9.097

Review 8.  Drug-induced myoclonus: frequency, mechanisms and management.

Authors:  Félix Javier Jiménez-Jiménez; Inmaculada Puertas; María de Toledo-Heras
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 9.  Neurologic Complications in the Intensive Care Unit.

Authors:  Clio Rubinos; Sean Ruland
Journal:  Curr Neurol Neurosci Rep       Date:  2016-06       Impact factor: 5.081

Review 10.  Cefepime-induced nonconvulsive status epilepticus: case report and review.

Authors:  Farah Thabet; Mohamed Al Maghrabi; Ahmed Al Barraq; Brahim Tabarki
Journal:  Neurocrit Care       Date:  2008-11-25       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.